2021
DOI: 10.1038/s41467-021-25844-5
|View full text |Cite
|
Sign up to set email alerts
|

Identification of limb-specific Lmx1b auto-regulatory modules with Nail-patella syndrome pathogenicity

Abstract: LMX1B haploinsufficiency causes Nail-patella syndrome (NPS; MIM 161200), characterized by nail dysplasia, absent/hypoplastic patellae, chronic kidney disease, and glaucoma. Accordingly in mice, Lmx1b has been shown to play crucial roles in the development of the limb, kidney and eye. Although one functional allele of Lmx1b appears adequate for development, Lmx1b null mice display ventral-ventral distal limbs with abnormal kidney, eye and cerebellar development, more disruptive, but fully concordant with NPS. I… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
29
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 19 publications
(31 citation statements)
references
References 36 publications
(64 reference statements)
2
29
0
Order By: Relevance
“…As outlined above, master TFs whose HI leads to DDs are generally involved in positive feedback ( and ). Crucially, for many of these TFs, disruption of positive feedback has been identified as the cause of human disease, including LMX1B in nail–patella syndrome ( Haro et al, 2021 ), PAX6 in aniridia ( Bhatia et al, 2013 ), SOX10 in Waardenburg syndrome ( Lecerf et al, 2014 ), SOX9 in sex reversal ( Croft et al, 2018 ), FOXG1 in FOXG1 syndrome ( Ye et al, 2022 ), FOXP2 in speech–language disorder ( Becker et al, 2018 ), NFIA in a brain malformation syndrome ( Trevino et al, 2021 ), GATA2 in immunodeficiency ( Johnson et al, 2012 ), and HNF1A and HNF4A in MODY ( Hansen et al, 2002 ). If disruption of positive feedback is due to loss-of-function mutations in CREs (regulatory loss of function; Box 2 ), this frequently results in the isolated, rather than the syndromic, form of the disorder.…”
Section: A Unified Explanatory Frameworkmentioning
confidence: 99%
See 1 more Smart Citation
“…As outlined above, master TFs whose HI leads to DDs are generally involved in positive feedback ( and ). Crucially, for many of these TFs, disruption of positive feedback has been identified as the cause of human disease, including LMX1B in nail–patella syndrome ( Haro et al, 2021 ), PAX6 in aniridia ( Bhatia et al, 2013 ), SOX10 in Waardenburg syndrome ( Lecerf et al, 2014 ), SOX9 in sex reversal ( Croft et al, 2018 ), FOXG1 in FOXG1 syndrome ( Ye et al, 2022 ), FOXP2 in speech–language disorder ( Becker et al, 2018 ), NFIA in a brain malformation syndrome ( Trevino et al, 2021 ), GATA2 in immunodeficiency ( Johnson et al, 2012 ), and HNF1A and HNF4A in MODY ( Hansen et al, 2002 ). If disruption of positive feedback is due to loss-of-function mutations in CREs (regulatory loss of function; Box 2 ), this frequently results in the isolated, rather than the syndromic, form of the disorder.…”
Section: A Unified Explanatory Frameworkmentioning
confidence: 99%
“…If disruption of positive feedback is due to loss-of-function mutations in CREs (regulatory loss of function; Box 2 ), this frequently results in the isolated, rather than the syndromic, form of the disorder. For example, LMX1B regulatory loss of function results in limb anomalies rather than full nail–patella syndrome ( Haro et al, 2021 ), SOX10 regulatory loss of function results in isolated Hirschsprung's disease rather than Waardenburg syndrome ( Lecerf et al, 2014 ), and FOXG1 regulatory loss of function results in isolated strabismus rather than FOXG1 syndrome ( Ye et al, 2022 ). The reason is that most CREs are tissue-specific and will, when mutated, only affect that tissue.…”
Section: A Unified Explanatory Frameworkmentioning
confidence: 99%
“…We have recently characterized two limb-specific Lmx1b enhancers, termed LARM1 and LARM2 , that mediate Lmx1b limb dorsalization (Haro et al 2021). Mice homozygous for the removal of these two enhancers ( ΔLARM1/2 ) replicate the Lmx1b-null limb phenotype consisting of double-ventral distal limbs with sole pads in both surfaces and no nails (Haro et al 2021; Fig 1A-A’).…”
Section: Resultsmentioning
confidence: 99%
“…We have recently characterized two limb-specific Lmx1b enhancers, termed LARM1 and LARM2 , that mediate Lmx1b limb dorsalization (Haro et al 2021). Mice homozygous for the removal of these two enhancers ( ΔLARM1/2 ) replicate the Lmx1b-null limb phenotype consisting of double-ventral distal limbs with sole pads in both surfaces and no nails (Haro et al 2021; Fig 1A-A’). In contrast to Lmx1b-null mutants that die perinatally, ΔLARM1/2 homozygous mutants survive, as they show no other Lmx1b-related systemic defects, allowing the analysis of fully differentiated double-ventral limbs.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation